Navigation Links
Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
Date:7/30/2009

LAVAL, QC, July 30 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced that James R. Howard-Tripp, Chief Executive Officer of the Company, will present at the Canaccord Adams 29th Annual Global Growth Conference at the InterContinental Boston, on Tuesday, August 11, 2009 at 3:30 p.m. ET.

Interested parties may access the live webcast for this presentation by visiting the "Events" section of the homepage of the Company's website at www.labopharm.com. Please connect at least 15 minutes prior to the presentation to ensure adequate time for any software download that may be required to join the webcast. An audio archive of the presentation will be available for 30 days.

About Labopharm Inc.

Labopharm is an emerging leader in optimizing the performance of existing small molecule drugs using its proprietary controlled-release technologies. The Company's lead product, a unique once-daily formulation of tramadol, is now available in 17 countries around the world, including the U.S., Canada, major European markets and Australia. The Company's second product, a novel formulation of trazodone for the treatment of major depressive disorder, is under regulatory review in the U.S. by the FDA. The Company also has a robust pipeline of follow-on products in both pre-clinical and clinical development. Labopharm's vision is to become an integrated, international, specialty pharmaceutical company with the capability to internally develop and commercialize its own products. For more information, please visit www.labopharm.com.


'/>"/>
SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
2. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
3. Labopharm amends debt facility agreement with Hercules
4. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
5. Labopharm Reports Results for First Quarter Fiscal 2009
6. Labopharm announces details for first quarter results conference call and annual meeting
7. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
8. Labopharm to present at Cowen 29th Annual Health Care Conference
9. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
10. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
11. Labopharm to host conference call to discuss FDA approval of once-daily RYZOLT(TM) on Tuesday, January 6, 2009 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... News) -- Adults with dyslexia are more likely to ... teenagers than people who don,t have the learning disorder, ... affects up to 10 percent of people, causes problems ... of adults with this condition said they suffered physical ... those without dyslexia. "Even after accounting for age, ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... Forget about the Twitter wars that break out regularly between ... be bad for your own relationship, a new study suggests. ... within a couple, even if the couple is in a ... 581 Twitter users. In turn, that friction can lead ...
(Date:7/10/2014)... who research issues ranging from child abuse to urban ... the International Society for Research on Aggression (ISRA) at ... University is hosting the prestigious world meeting, which is ... are excited to be bringing together leading scholars from ... fresh ideas about the causes, consequences and solutions to ...
(Date:7/10/2014)... known as the "Mississippi baby" an infant seemingly cured ... a prolonged remission of HIV infection in The New ... of HIV after more than two years of not taking ... HIV specialist and researchers involved in the case. ... this young child, the medical staff involved in the child,s ...
(Date:7/10/2014)... medical imaging far outweigh the risks when children receive ... Right Radiation Dose. However, overuse and misuse of imaging ... a collaborative effort to ensure a national protocol is ... Journal of Patient Safety , calls for the ... Accreditation Commission, and the Centers for Medicare & Medicaid ...
Breaking Medicine News(10 mins):Health News:Researchers See Link Between Dyslexia, Abuse 2Health News:Are You Tweeting Your Marriage Away? 2Health News:Are You Tweeting Your Marriage Away? 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:'Mississippi Baby' now has detectable HIV, researchers find 2Health News:'Mississippi Baby' now has detectable HIV, researchers find 3Health News:Mayo Clinic calls for standardization of safe imaging protocols for children 2
... records and embedded tools can alert and direct pediatricians ... and teenagers, according to a new Kaiser Permanente study ... Researchers analyzed visits for nearly 740,000 children and ... of computer-assisted decision tools and found that extracting information ...
... News) -- Researchers who traced the evolution of a ... livestock to humans say their findings highlight the dangers ... The international team of scientists studied methicillin-resistant Staphylococcus ... livestock-associated MRSA, which most often infects people with direct ...
... you use your right hand to hold your cell phone up to ... in Detroit. The study finds a strong correlation between brain dominance ... than 70 percent of participants holding their cell phone up to the ... brain dominate people those whose speech and language center is on ...
... 2012 A simple blood test is being developed by ... University Medical Center in Beer-Sheva, Israel that may provide early ... BGU,s Faculty of Health Sciences and his team developed a ... of blood. The test uses infrared light to detect miniscule ...
... have discovered that cancer-causing genetic mutations have better-disguised electronic signatures ... them fly under the radar of the body,s defence mechanisms. ... University of Warwick and in Taiwan hint at the possibility ... a role in early diagnosis and detection of mutation hotspots. ...
... within each cell that regulate metabolism and energy use, ... according to a new study. Manipulation of two biochemical ... could shrink human lung cancers transplanted into mice, a ... FASEB . Within each cell, mitochondria are constantly ...
Cached Medicine News:Health News:Computer-assisted tools alert pediatricians to obese patients 2Health News:Computer-assisted tools alert pediatricians to obese patients 3Health News:Pig-to-Human 'Superbug' May Be Due to Animal Antibiotics 2Health News:Study: Brain makes call on which ear is used for cell phone 2Health News:Study: Brain makes call on which ear is used for cell phone 3Health News:'Stealth' properties of cancer-causing genetic mutations identified 2Health News:Energy network within cells may be new target for cancer therapy 2Health News:Energy network within cells may be new target for cancer therapy 3
(Date:1/15/2014)... the leading health care supply chain expertise, analytics and ... national contracts that expand its portfolio to provide hospital ... These include manufacturer product and service agreements, as well ... IT consulting support. New Novation agreements ...
(Date:1/15/2014)... FORT WORTH, Texas , Jan. 15, 2014  Humberto ... in Dermatology Achievement Award" from the Journal of ... Dermatology Aesthetic & Clinical Conference (ODAC). The event is January ... Florida . The ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very ... King as its new Chief Executive Officer.  Mark was ... which he has overseen the company,s four facilities in ... Costa Rica.  Mr. King joined Tegra Medical in 2012 with ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Medical Corporation has provided an educational grant to establish ... .  "Atrium has been proud to be the market ... McGill, Senior Vice President of Marketing and Corporate Communications. ... nurses and physicians, we decided to emphasize our commitment ...
... 15, 2011 Johnson & Johnson (NYSE: ... agreement with Merck regarding distribution rights for REMICADE® (infliximab) ... The amended agreement announced today in a separate news ... had been filed by Johnson & Johnson in May ...
Cached Medicine Technology:Atrium Provides Grant to Establish Education Web Site at AtriumU.com 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 2Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck 3
... is a potent naturally occurring androgen ... of cholestenone 5a-reductase [1]. The ... certain peripheral tissues, including genital skin ... intra-cellularly in apparent association with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
UROSKOP Access, the dedicated urodiagnostic table with truly unrestricted patient access optimizes nearly all diagnostic and interventional procedures....
Drew Scientific has been making leading edge and top quality CBC systems for over 15 years.,The Excell 16/18 offers a reliable alternative for a 3 part differential....
Medicine Products: